ArticleCPT: pharmacometrics & systems pharmacology2022

Exposure-response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors.

Anu Shilpa Krishnatry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.